Tokyo · Stocky rates: Hold

LIVERO INC (9245.T)

¥1,949.00 ▲ +0.57% as of 24 Aug, 13:12

Stocky turns companies like LIVERO INC into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.

Try Stocky free →
70
/ 100
Hold

What Stocky thinks

Hold. 9245.T earns a solid Growth Compounder Score (82/100) driven by consistent revenue expansion, but Leadership Alignment (52/100) lags—suggesting misalignment between insider incentives and shareholder returns. Vulnerability Index at 100 indicates material structural or operational risks that offset growth upside, warranting patience for clarity on management capital allocation or moat durability before committing fresh capital.

Compounder Score
80/100
Business quality — profitability, growth, capital efficiency.
Leadership Alignment
52/100
Founder-led, insider ownership, capital allocation history.
Vulnerability
100/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Value Score
59/100
Valuation vs peers and history — is this a good price to pay?

What Stocky gives investors that other tools don't

Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for LIVERO INC:

70
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 70/100, you know instantly whether to dig deeper or skip.

Rated
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

52
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

100
RISK

Vulnerability Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

LIVERO INC (9245.T) — frequently asked

Is LIVERO INC (9245.T) a good investment right now?

Stocky rates LIVERO INC (9245.T) at 70/100 — a Hold — quality is solid but valuation or risk factors cap upside. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Hold. 9245.T earns a solid Growth Compounder Score (82/100) driven by consistent revenue expansion, but Leadership Alignment (52/100) lags—suggesting misalignment between insider incentives and shareholder returns. Vulnerability Index at 10

What is 9245.T's Stocky Verdict?

9245.T's current Stocky Verdict is 70/100, placing it in the "Hold" band. This composite combines a 80/100 Compounder score, 52/100 Leadership, Moat rating, and analyst signal.

Does LIVERO INC have a competitive moat?

Stocky hasn't finalised a Moat Score for LIVERO INC yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.

Is LIVERO INC's leadership aligned with shareholders?

LIVERO INC scores 52/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.

What are the biggest risks to 9245.T?

LIVERO INC's Vulnerability Profile scores 100/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to LIVERO INC.

This is just the surface. See the whole picture on LIVERO INC.

Sign up free and unlock the full analysis on 9245.T — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering 9245.T — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Vulnerability Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for 9245.T.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how 9245.T changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to 9245.T?" · "Is 9245.T overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
70
/ 100 · Hold

See LIVERO INC the Stocky way

This page is just a preview. Open the live, interactive version for the full picture:

Stocky Verdict
A plain-English Buy / Hold / Sell score out of 100.
Compounder & Value scores
How strong the business is — and whether it looks cheap.
Interactive charts
1M to 5Y price history with company events plotted on it.
Top analyst targets
What the best-rated Wall Street analysts expect next.
What if? simulator
See what an investment in 9245.T would be worth today.
Practice portfolio
Buy 9245.T with virtual money and track it — zero risk.
Free · no real money · learn by doing Open 9245.T in Stocky →

Or jump straight to the interactive dashboard for 9245.T in the app.